On Thursday, Medicare turns sixty-one. That is not a round number and nobody will mark it, but it is worth two minutes of your time — because the single most useful thing about Medicare's history is that it explains the thing that confuses people most about it today.
Today: why "Medicare covers it" is never one answer, a recall on an allergy tablet you may have in the house right now, the free application people are being charged for, a payment rule that could quietly make home health harder to get, the question that gets a medication taken off your list, and the year the first baby boomers turned eighty.
📰 The Big Story
Medicare Turns 61 — and It Still Isn't Finished
On July 30, 1965, Lyndon Johnson signed Medicare and Medicaid into law. He did not sign it in Washington. He flew to Independence, Missouri, to the Harry S. Truman Library, and signed it in front of Truman himself — because twenty years earlier, on November 19, 1945, Truman had asked Congress to create national health insurance, and been beaten. Standing beside him, Johnson said: "But it all started really with the man from Independence." In the room that day: the Johnsons, the Trumans, the president of the AFL-CIO, a cabinet secretary, a governor, thirteen senators and nineteen representatives.
Here is a small correction to a story you have probably heard, including from us. It is often said that Truman received the first Medicare card that afternoon. He didn't. What he got on July 30 was one of the commemorative pens. He and Bess received the first two Medicare cards six months later, on January 20, 1966, hand-delivered by Johnson on a return visit to the library. And nobody's coverage actually began until July 1, 1966 — a full year after the signing.
That gap is the whole point.
Medicare did not arrive finished, and it never has. What the 1965 law created was Part A, for hospital stays, and Part B, for doctors. That was it. Nearly 20 million people enrolled in the first three years, into a program with two parts.
Now count what wasn't there.
There was no outpatient prescription drug coverage in Medicare at all until January 1, 2006 — when Part D began — more than forty years after the signing. And there was no limit whatsoever on what Part D could cost you in a year until January 1, 2025, when a $2,000 annual out-of-pocket cap took effect for the first time. That cap is indexed, so it is $2,100 this year.
Why this matters, today, to you: almost every part of Medicare that people get wrong is a part that was bolted on later — and the bolted-on parts are the ones you have to actively choose. Part A arrives on its own. Part B mostly arrives on its own. Part D does not choose itself. Neither does a Medigap policy, or a Medicare Advantage plan. When someone says "I thought Medicare covered that," they are almost always describing something that Medicare, in 1965, genuinely did not — and that in 2026 you have to opt into.
What to do this week: nothing urgent, and that is deliberate. But open enrollment runs October 15 to December 7, and the useful work happens before it starts, not during. Between now and then, know the answer to two questions: which drug plan you are in, and whether you have a supplement. If either answer is "I'm not sure," that is the thing to find out while there is no deadline attached to it.
📡 On Your Radar
Three short things worth knowing.
💊 An allergy tablet was recalled over contamination with a drug pulled from the market in 2020. On July 18, Unique Pharmaceutical Laboratories recalled four lots of cetirizine hydrochloride 5 mg tablets — the generic of Zyrtec — down to the consumer level, for possible cross-contamination with ranitidine. Ranitidine is the heartburn drug sold as Zantac, which the FDA asked manufacturers to pull from the market entirely on April 1, 2020 after finding a probable carcinogen in it that increases over time. This is over-the-counter cetirizine, so no prescription slip makes you exempt — but the recall is narrow and specific, and the specifics are the whole point. It covers four lots — GY825029, GY825030, GY825031 and GY825032, all expiring October 2028 — in the 100-tablet bottle distributed by Rising Pharma Holdings, the large bottle a pharmacy fills from rather than a small retail box. The risk is to people hypersensitive to ranitidine, for whom the FDA says a reaction could be severe. No injuries had been reported. What to do: if you have a bottle of cetirizine 5 mg in the house, don't reason from where you bought it — turn it over and read the lot number. If it's one of those four, stop taking it and call the pharmacy. The best detail in the whole story: this was caught because a pharmacy technician noticed a red dot on some of the tablets while counting them out.
🎖️ Applying for VA benefits is free. People are being charged for it. The FTC put out an alert on July 27 about a persistent one: scammers presenting themselves as the Department of Veterans Affairs, or as helpers with an inside track, and charging a fee to file a benefits application. There is no fee. Filing with the VA costs nothing, and free accredited help exists — through the VA itself and through veterans service organizations. The rule to keep: anyone who charges you to apply for a federal benefit is either breaking the law or selling you something you can get for free. This one travels through word of mouth in exactly the communities most likely to qualify, which is why it keeps working.
🏠 A payment rule that could make home health harder to get. This one is dull on the surface and worth ninety seconds anyway. On July 1, CMS proposed its 2027 payment rule for Medicare home health. The headline is a 2.4% increase. Inside it is a proposed temporary 3% cut to the base payment rate, to claw back what CMS says were overpayments under the payment model it adopted in 2020. Why this matters: nobody sends you a letter saying you no longer qualify for home health. The risk with payment changes like this one is quieter — agencies in thin markets can stop taking new Medicare patients, or stop covering outlying counties, and a benefit you are still fully entitled to becomes harder to actually use. That is a risk, not a forecast; the rule is still only proposed. The comment period is open through August 31 if you or an agency you rely on wants to say something on the record. (Editor's note added August 31, 2026: that window closes today. The final rule is expected in the autumn.)
💡 Worth Knowing
The question that gets a medication taken off your list
Here is something the research is unusually clear about, and it has nothing to do with any particular drug.
Doctors know that older patients often accumulate medications that made sense once and don't anymore. Stopping them has a name — deprescribing — and it is genuinely good medicine. It also almost never happens on its own, because nothing in a fifteen-minute appointment forces anyone to look at the whole list.
A randomized trial published in JAMA this year tested something almost insultingly simple: send the doctor a reminder. Researchers worked with 201 primary care physicians and 1,146 patients, and prompted some of the doctors — through the electronic record — to have a deprescribing conversation. Over roughly ten months, 26.8% of patients under usual care had at least one medication stopped. Among doctors who got the nudge, it was 36.8% and 34.3%, depending on the version.
That is a large difference, and the intervention was a reminder. Nothing about the medicine changed. What changed was that somebody was prompted to look.
Which means the prompt can come from you. Put every bottle in a bag — prescriptions, the over-the-counter things, the vitamins and supplements, including the ones you'd feel silly mentioning — take the bag to one appointment, and ask a single question: "Which of these can come off?" Not are these safe together, which invites a yes. Which can come off. Pharmacists will do this too, and often have more time for it than your doctor does.
If the answer is "none, and here's why for each one," that is a good visit. You will have learned something either way.
📖 From the Archives
Medigap, Explained Properly
Since the big story is really about the parts of Medicare you have to choose on purpose, this is the one people understand least and regret most. Medigap policies are standardized by letter, which sounds simple and isn't, and the moment when you can buy one without being asked about your health is narrower than almost anyone realizes — miss it, and in most states insurers can price you on your medical history or turn you down.
Worth reading before October, not during.
☕ Slice of Life
One more thing about anniversaries. Medicare turns sixty-one this week. And this year, the first baby boomers turn eighty.
Anyone born in 1946 hits eighty in 2026. Dolly Parton got there in January. Cher in May. Sylvester Stallone three weeks ago, on the sixth of July.
Sit with the arithmetic for a second. When Johnson signed that bill in Independence, the oldest boomers were nineteen years old — not the people Medicare was written for, but the children of them, out of high school, nowhere near thinking about any of this. The program was designed by one generation, for their parents, while that generation's own kids were still teenagers.
Those teenagers are eighty now. Same program, still being rewritten around them.
That's the week. Look at the lot number if you take cetirizine, and put the bag of bottles somewhere you'll see it before your next appointment.
— Nino
P.S. The bag-of-bottles thing is the single most useful item in this issue and the easiest to skip. If you do one thing from this email, do that one. Forward it to whoever manages the pills in your house — often that isn't the person taking them. I read every reply.
